The 16th Round in the News

March 13, 2013-Pharma battle threatens to delay Pacific trade pact (The Manila Times)

March 11, 2013- Don't sell our health for foreign investment (Dominion Post)

March 10, 2013-Canada, Mexico Brief TPP Countries on Pharmaceutical IPR Regimes (Inside U.S. Trade)

March 8, 2013-TPP Countries Poised to Revisit U.S. Access to Medicines Proposal (Inside U.S. Trade)

March 7, 2013- U.S. Will Not Table Texts On Tobacco, SPS Enforceability At TPP Round (Inside US Trade)

March 6, 2013-Put health ahead of profits in Asia-Pacific trade pact (The Australian)

March 6, 2013-In TPP, Canada Seeks Access To Certain Sub-federal Procurement Deals (Inside US Trade)

March 6, 2013- Put health ahead of profits in Asia-Pacific trade pact (The Australian)

March 5, 2013- TPP Schedule Reveals Most Focus on Environment, IPR, Legal Issues (Inside U.S. Trade)

March 5, 2013- U.S. “Stalling” Could Force Acceptance of Onerous TPP (IPS)

March 5, 2013- Civil Society Groups Ask For Revamped Fast-Track, Outline Trade Priorities (Inside Us Trade)

March 4, 2013Press Release: Ahead of Singapore Round of Trans-Pacific Partnership Negotiations, U.S. Public Opposition to Deal Grows (Public Citizen)

March 4, 2013- US trade policy putting public health at risk (Oxfam)

March 4, 2013-As Clock Ticks Toward Trans-Pacific Trade Pact Deadline, U.S. Must End Stall Tactics on Access to Medicines (Access
Campaign MSF)

March 4, 2013- Over 400 Groups Urge Replacement of Outdated “Fast Track” and a New Direction for the Trans-Pacific Partnership and Other 21st Century Trade Agreements (Citizens Trade Campaign)

March 3, 2013- Press Release: Doctors and nurses warn Prime Minister over trade talks (Scoop)

March 1, 2013- Emerging threats to public health from regional trade agreements (The Lancet)

March 1, 2013-Farmacéuticos temen que TPP afecte bajo costo de remedios (Terra)

February 26, 2013- Trans Pacific Partnership Secret Talks Continue (West Orlando)

February 21, 2013
- Sources: USTR To Float New Access to Medicines Ideas At Next TPP Round (Inside U.S. Trade)



Round 16 : Singapore

March 4-13, 2013





Over 400 groups urge a New Direction for the Trans-Pacific Partnership and Other 21st Century Trade Agreements, March 4, 2013


News from the Singapore Round

The 16th and latest round of the Trans-Pacific Partnership negotiations took place in Singapore between March 4th and 13th. During this round, negotiators focused mainly on enforcement issues. They began with a discussion on civil and criminal enforcement measures, in which, according to sources, negotiators reached consensus on certain parts of the text. Up until this round, Canada, Mexico and Singapore were the only countries that had not indicated their opposition to the US proposal on pharmaceuticals, known as the TEAM paper.It has been speculated that they finally stated their positions in Singapore. Read More


New Factsheets

Letter and Statements


March 6, 2013 is "Access to Medicines" Day

March 10, 2013 Lunch for Intellectual Property and Investment Negotiators

Access to Medicines & Investor Privileges under Free Trade Agreements: The Case of Eli Lilly


News from Singapore

Stakeholder Briefing, March 6, 2013

Chief negotiators (CN) provide an update on the round to stakeholders.

      




















Back to TPP page

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.